查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
到 2030 年美國和歐洲基因編輯市場預測 - 按技術、產品和服務、應用程式和最終用戶進行的國家/地區分析
市場調查報告書
商品編碼
1347189

到 2030 年美國和歐洲基因編輯市場預測 - 按技術、產品和服務、應用程式和最終用戶進行的國家/地區分析

US and Europe Gene Editing Market Forecast to 2030 - Country Analysis by Technology, Product and Service, Application, and End User
出版日期: | 出版商: The Insight Partners | 英文 146 Pages | 訂單完成後即時交付

價格

美國和歐盟基因編輯市場預計將從2022年的39.5509億美元增至2030年的150.5292億美元；預計2022年至2030年年複合成長率為18.2%。

癌症和其他遺傳性疾病患病率的上升以及基因編輯工具的持續技術進步等因素預計將推動美國和歐盟基因編輯市場的成長。此外，生物技術不斷成長的創新和不斷增加的投資預計也將在預測期內促進美國和歐盟基因編輯市場的成長。然而，基因編輯方法的高生產成本可能會阻礙美國和歐盟基因編輯市場的成長。

市場參與者開發新產品的戰略舉措，以推動未來美國和歐盟基因編輯市場的發展

醫療保健 IT 領域的技術發展允許使用人工智慧 (AI) 來製造 CRISPR 系統。醫療保健 IT 領域的開發人員致力於分析流程，以控制和監控產品開發的所有階段。重點是開發從發現生物標記到臨床試驗和患者監測的技術。一些公司已經開始運用他們的專業知識，將人工智慧用於數位製造。 2023 年 2 月，開發 CRISPR、合成生物學和人工智慧 (AI) 技術的 Sherlock Biosciences 收購了 Sense Biodetection，這是一家位於英國牛津的快速分子檢測平台開發商。此次收購增強了 Sherlock 將最先進的基於 CRISPR 的診斷技術方便地交付給全球消費者的能力。

2020年1月，ERS Genomics和New England Biolab合作開發並商業化CRISPR基因修飾工具和試劑。新英格蘭生物實驗室為基因組研究提供最齊全的重組酶和天然酶選擇。該公司繼續將其產品擴展到新的研究領域，包括基因組編輯。作為 CRISPR/Cas9 試劑和工具的提供商，NEB 從 ERS ​​Genomics 獲得的許可擴大了該公司使用和銷售這些技術的權利。

因此，此類舉措預計將在未來幾年促進基因組編輯並促進美國和歐盟基因編輯市場的成長。

美國和歐盟基因編輯市場根據技術、產品和服務、應用和最終用戶進行細分。根據技術分為 CRISPR、TALEN、反義、鋅指核酸酶 (ZFN) 等。 2022年，CRISPR細分市場佔據美國和歐盟基因編輯市場的最大佔有率。此外，預計同一細分市場在未來幾年也將以最快的速度成長。根據產品和服務分為試劑和耗材、儀器和其他。 2022年，試劑和耗材領域在美國和歐盟基因編輯市場中佔據最大佔有率。此外，預計同一細分市場在未來幾年也將以最快的速度成長。根據應用分為細胞系工程、基因工程、診斷應用、藥物發現等。 2022年，細胞系工程領域佔據最大的市場佔有率。此外，預計同一細分市場在未來幾年也將以最快的速度成長。根據最終用戶分為製藥和生物技術公司、學術和研究機構、契約研究組織 (CRO) 等。 2022年，製藥和生物技術公司細分市場在美國和歐盟基因編輯市場中佔據最大佔有率。然而，學術和研究機構部門預計在未來幾年將以最快的速度成長。

世界衛生組織 (WHO)、農業基因組學研究中心 (CRAG)、疾病控制與預防中心 (CDC)、環境、食品和農村事務部 (DEFRA)、糧食及農業組織 (FAO)、美國美國和歐盟基因編輯市場報告在準備時參考了一些主要和次要來源，其中包括美國食品和藥物管理局(FDA)、義大利農業遺傳學會(SIGA)。

目錄

第 1 章：簡介

  • 研究範圍
  • Insight Partners 研究報告指南
  • 市場區隔
    • 美國和歐洲基因編輯市場-按技術分類
    • 美國和歐洲基因編輯市場 - 按產品和服務分類
    • 美國和歐洲基因編輯市場- 按應用
    • 美國和歐洲基因編輯市場 - 按最終用戶分類
    • 基因編輯市場-按地域分類

第 2 章：執行摘要

第 3 章：研究方法

  • 覆蓋範圍
  • 二次研究
  • 初步研究

第 4 章：美國和歐洲基因編輯市場 - 市場格局

  • 概述
  • PEST分析
    • 美國 - PEST 分析
    • 歐洲 - PEST 分析
  • 專家意見

第 5 章：基因編輯市場 - 主要市場動態

  • 市場促進因素
    • 癌症和其他遺傳性疾病患病率上升
    • 基因編輯工具的持續技術進步
  • 市場限制
    • 基因編輯方法的生產成本高
  • 市場機會
    • 美國和歐洲不斷發展的生物技術產業
  • 未來的趨勢
    • 市場參與者開發新產品的戰略舉措
  • 影響分析

第 6 章：基因編輯市場 - 美國和歐洲分析

  • 美國和歐洲基因編輯市場收入預測與分析
  • 關鍵參與者的市場定位

第 7 章：美國和歐洲基因編輯市場分析 - 按技術

  • 概述
  • 基因編輯技術
  • 泰倫
  • 反義
  • 鋅指核酸酶 (ZFN)
  • 其他

第 8 章：美國和歐洲基因編輯市場分析 - 按產品和服務

  • 概述
  • 試劑及耗材
  • 儀器
  • 其他

第 9 章：美國和歐洲基因編輯市場分析 -按應用

  • 概述
  • 細胞系工程
  • 基因工程
  • 診斷應用
  • 藥物發現
  • 其他

第 10 章：美國和歐洲基因編輯市場分析 - 按最終用戶

  • 概述
  • 製藥與生物技術公司
  • 學術及研究機構
  • 契約研究組織 (CRO)
  • 其他

第 11 章：美國和歐洲基因編輯市場分析

  • 美國基因編輯市場收入預測與分析
    • 概述
  • 歐洲基因編輯市場收入預測與分析
    • 概述

第 12 章：行業格局

  • 概述
  • 美國和歐洲基因編輯市場的成長策略
  • 有機成長策略
    • 概述
  • 無機成長策略
    • 概述

第 13 章：公司簡介

  • Thermo Fisher Scientific Inc
  • Merck KGaA
  • Lonza Group AG
  • Horizon Discovery Group plc.
  • Integrated DNA Technologies, Inc.
  • GenScript Biotech Corporation
  • New England Biolabs
  • Eurofins Scientific SE
  • CRISPR Therapeutics
  • Editas Medicine Inc
  • ElevateBio LLC

第 14 章：附錄

  • 專業術語
Product Code: TIPRE00029986

The US & EU gene editing market is projected to reach US$ 15,052.92 million by 2030 from US$ 3,955.09 million in 2022; it is expected to grow at a CAGR of 18.2% from 2022 to 2030.

The factors such as rise in the prevalence of cancer and other genetic disorders and continuous technological advancements in gene editing tools are expected to drive the US & EU gene editing market growth. Moreover, growing innovations and rising investments in biotechnology is also expected to foster the US & EU gene editing market growth during the forecast period. However, the high cost of production of gene editing methods may hinder the US & EU gene editing market growth.

Strategic Initiatives by Market Players to Develop New Products to Boost the US & EU Gene Editing Market in Future

Technological developments in healthcare IT allow the use of artificial intelligence (AI) for manufacturing CRISPR Systems. Developers working in the healthcare IT domain are engaged in analyzing the processes to control and monitor all the stages of product development. The focus is to develop technologies from discovering biomarkers to clinical trials and patient monitoring. A few companies have initiated implementing their expertise to use AI for digital manufacturing. In February 2023, Sherlock Biosciences, which develops CRISPR, synthetic biology, and artificial intelligence (AI) technologies, acquired Sense Biodetection, an Oxford, UK-based developer of a rapid molecular testing platform. This acquisition accelerates Sherlock's ability to put the most advanced CRISPR-based diagnostics conveniently in the hands of global consumers.

In January 2020, ERS Genomics and New England Biolab collaborated to develop and commercialize CRISPR gene modification tools and reagents. New England Biolab offers the largest selection of recombinant and native enzymes for genomic research. The company continues expanding its product offerings into new research areas, including genome editing. As a provider of CRISPR/Cas9 reagents and tools, NEB's license from ERS Genomics expands the company's rights to use and sell these technologies.

Thus, such initiatives are expected to foster genome editing and enhance the US & EU gene editing market growth in the coming years.

The US & EU gene editing market is segmented on the basis of technology, product and services, application, and end user. Based on the technology is segmented into CRISPR, TALEN, antisense, Zinc Finger Nucleases (ZFNs), and others. In 2022, the CRISPR segment held the largest share of the US & EU gene editing market. Moreover, the same segment is also expected to grow at the fastest rate during the coming years. Based on the products and services is segmented into reagents and consumables, instruments, and others. In 2022, the reagents and consumables segment held the largest share of the US & EU gene editing market. Moreover, the same segment is also expected to grow at the fastest rate during the coming years. Based on the application is segmented into cell line engineering, genetic engineering, diagnostic application, drug discovery, and others. In 2022, the cell line engineering segment held the largest share of the market. Moreover, the same segment is also expected to grow at the fastest rate during the coming years. Based on the end user is segmented into pharmaceutical & biotechnology companies, academic and research institutes, contract research organization (CROs), others. In 2022, the pharmaceutical & biotechnology companies segment held the largest share of the US & EU gene editing market. However, the academic and research institutes segment is expected to grow at the fastest rate during the coming years.

The World Health Organization (WHO), Centre For Research in Agricultural Genomics (CRAG), Centers for Disease Control and Prevention (CDC), Department For Environment, Food, And Rural Affairs (DEFRA), Food And Agricultural Organization (FAO), US Food and Drug Administration (FDA), Italian Society of Agricultural Genetics (SIGA) are among some of the primary and secondary sources referred to while preparing the report on the US & EU gene editing market.

Reasons to Buy:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the US and Europe Gene editing market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the US and Europe Gene editing market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Table Of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 US and Europe Gene Editing Market- By Technology
    • 1.3.2 US and Europe Gene Editing Market- By Products and Services
    • 1.3.3 US and Europe Gene Editing Market- By Application
    • 1.3.4 US and Europe Gene Editing Market- By End User
    • 1.3.5 Gene Editing Market- By Geography

2. Executive Summary

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. US and Europe Gene Editing Market - Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 US - PEST Analysis
    • 4.2.2 Europe - PEST Analysis
  • 4.3 Expert Opinions

5. Gene Editing Market - Key Market Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Rise in Prevalence of Cancer and Other Genetic Disorders
    • 5.1.2 Continuous Technological Advancements in Gene Editing Tools
  • 5.2 Market Restraints
    • 5.2.1 High Cost of Production of Gene Editing Methods
  • 5.3 Market Opportunities
    • 5.3.1 Growing Biotechnology Industry in US and Europe
  • 5.4 Future Trends
    • 5.4.1 Strategic Initiatives by Market Players to Develop New Products
  • 5.5 Impact Analysis

6. Gene Editing Market - US and Europe Analysis

  • 6.1 US and Europe Gene Editing Market Revenue Forecast and Analysis
  • 6.2 Market Positioning of Key Players

7. US and Europe Gene Editing Market Analysis - By Technology

  • 7.1 Overview
    • 7.1.1 US and Europe Gene Editing Market, By Technology 2022 & 2030 (%)
  • 7.2 CRISPR
    • 7.2.1 Overview
    • 7.2.2 US and Europe CRISPR Market Revenue and Forecasts to 2030 (US$ Million)
  • 7.3 TALEN
    • 7.3.1 Overview
    • 7.3.2 US and Europe TALEN Market Revenue and Forecasts to 2030 (US$ Million)
  • 7.4 Antisense
    • 7.4.1 Overview
    • 7.4.2 US and Europe Antisense Market Revenue and Forecasts to 2030 (US$ Million)
  • 7.5 Zinc Finger Nucleases (ZFNs)
    • 7.5.1 Overview
    • 7.5.2 US and Europe Zinc Finger Nucleases (ZFNs)Market Revenue and Forecasts to 2030 (US$ Million)
  • 7.6 Others
    • 7.6.1 Overview
    • 7.6.2 US and Europe Others Market Revenue and Forecasts to 2030 (US$ Million)

8. US and Europe Gene Editing Market Analysis - By Products and Services

  • 8.1 Overview
    • 8.1.1 US and Europe Gene Editing Market, By Products and Services 2022 & 2030 (%)
  • 8.2 Reagents and Consumables
    • 8.2.1 Overview
    • 8.2.2 US and Europe Reagents and Consumables Market Revenue and Forecasts to 2030 (US$ Million)
  • 8.3 Instruments
    • 8.3.1 Overview
    • 8.3.2 US and Europe Instruments Market Revenue and Forecasts to 2030 (US$ Million)
  • 8.4 Others
    • 8.4.1 Overview
    • 8.4.2 US and Europe Others Market Revenue and Forecasts to 2030 (US$ Million)

9. US and Europe Gene Editing Market Analysis - By Application

  • 9.1 Overview
    • 9.1.1 US and Europe Gene Editing Market, By Application 2022 & 2030 (%)
  • 9.2 Cell Line Engineering
    • 9.2.1 Overview
    • 9.2.2 US and Europe Cell Line Engineering Market Revenue and Forecasts to 2030 (US$ Million)
  • 9.3 Genetic Engineering
    • 9.3.1 Overview
    • 9.3.2 US and Europe Genetic Engineering Market Revenue and Forecasts to 2030 (US$ Million)
  • 9.4 Diagnostic Application
    • 9.4.1 Overview
    • 9.4.2 US and Europe Diagnostic Application Market Revenue and Forecasts to 2030 (US$ Million)
  • 9.5 Drug Discovery
    • 9.5.1 Overview
    • 9.5.2 US and Europe Drug Discovery Market Revenue and Forecasts to 2030 (US$ Million)
  • 9.6 Others
    • 9.6.1 Overview
    • 9.6.2 US and Europe Others Market Revenue and Forecasts to 2030 (US$ Million)

10. US and Europe Gene Editing Market Analysis - By End User

  • 10.1 Overview
    • 10.1.1 US and Europe Gene Editing Market, By End User 2022 & 2030 (%)
  • 10.2 Pharmaceutical & Biotechnology Companies
    • 10.2.1 Overview
    • 10.2.2 US and Europe Pharmaceutical & Biotechnology Companies Market Revenue and Forecasts to 2030 (US$ Million)
  • 10.3 Academic and Research Institutes
    • 10.3.1 Overview
    • 10.3.2 US and Europe Academic and Research Institutes Market Revenue and Forecasts to 2030 (US$ Million)
  • 10.4 Contract Research Organization (CROs)
    • 10.4.1 Overview
    • 10.4.2 US and Europe Contract Research Organization (CROs) Market Revenue and Forecasts to 2030 (US$ Million)
  • 10.5 Others
    • 10.5.1 Overview
    • 10.5.2 US and Europe Others Market Revenue and Forecasts to 2030 (US$ Million)

11. US and Europe Gene Editing Market Analysis

  • 11.1 US Gene Editing Market Revenue Forecast and Analysis
    • 11.1.1 Overview
    • 11.1.2 US: Gene Editing Market - Revenue and Forecasts to 2030 (USD Million)
    • 11.1.3 US: Gene Editing Market- Revenue and Forecasts to 2030, By Technology (USD Million)
    • 11.1.4 US: Gene Editing Market- Revenue and Forecasts to 2030, By Products and Services (USD Million)
    • 11.1.5 US: Gene Editing Market- Revenue and Forecasts to 2030, By Application (USD Million)
    • 11.1.6 US: Gene Editing Market- Revenue and Forecasts to 2030, By End User (USD Million)
  • 11.2 Europe Gene Editing Market Revenue Forecast and Analysis
    • 11.2.1 Overview
    • 11.2.2 Europe: Gene Editing Market - Revenue and Forecasts to 2030 (USD Million)
    • 11.2.3 Europe: Gene Editing Market- Revenue and Forecasts to 2030, By Technology (USD Million)
    • 11.2.4 Europe: Gene Editing Market- Revenue and Forecasts to 2030, By Products and Services (USD Million)
    • 11.2.5 Europe: Gene Editing Market- Revenue and Forecasts to 2030, By Application (USD Million)
    • 11.2.6 Europe: Gene Editing Market- Revenue and Forecasts to 2030, By End User (USD Million)
    • 11.2.7 Europe: Gene Editing Market- Revenue and Forecasts to 2030, By Country (%)
    • 11.2.8 Germany: Gene Editing Market - Revenue and Forecast to 2030 (USD Million)
      • 11.2.8.1 Germany: Gene Editing Market - Revenue and Forecast to 2030 (USD Million)
      • 11.2.8.2 Germany: Gene Editing Market- Revenue and Forecasts to 2030, By Technology (USD Million)
      • 11.2.8.3 Germany: Gene Editing Market- Revenue and Forecasts to 2030, By Products and Services (USD Million)
      • 11.2.8.4 Germany: Gene Editing Market- Revenue and Forecasts to 2030, By Application (USD Million)
      • 11.2.8.5 Germany: Gene Editing Market- Revenue and Forecasts to 2030, By End User (USD Million)
    • 11.2.9 UK: Gene Editing Market - Revenue and Forecast to 2030 (USD Million)
      • 11.2.9.1 UK: Gene Editing Market - Revenue and Forecast to 2030 (USD Million)
      • 11.2.9.2 UK: Gene Editing Market- Revenue and Forecasts to 2030, By Technology (USD Million)
      • 11.2.9.3 UK: Gene Editing Market- Revenue and Forecasts to 2030, By Products and Services (USD Million)
      • 11.2.9.4 UK: Gene Editing Market- Revenue and Forecasts to 2030, By Application (USD Million)
      • 11.2.9.5 UK: Gene Editing Market- Revenue and Forecasts to 2030, By End User (USD Million)
    • 11.2.10 France: Gene Editing Market - Revenue and Forecast to 2030 (USD Million)
      • 11.2.10.1 France: Gene Editing Market - Revenue and Forecast to 2030 (USD Million)
      • 11.2.10.2 France: Gene Editing Market- Revenue and Forecasts to 2030, By Technology (USD Million)
      • 11.2.10.3 France: Gene Editing Market- Revenue and Forecasts to 2030, By Products and Services (USD Million)
      • 11.2.10.4 France: Gene Editing Market- Revenue and Forecasts to 2030, By Application (USD Million)
      • 11.2.10.5 France: Gene Editing Market- Revenue and Forecasts to 2030, By End User (USD Million)
    • 11.2.11 Italy: Gene Editing Market - Revenue and Forecast to 2030 (USD Million)
      • 11.2.11.1 Italy: Gene Editing Market - Revenue and Forecast to 2030 (USD Million)
      • 11.2.11.2 Italy: Gene Editing Market- Revenue and Forecasts to 2030, By Technology (USD Million)
      • 11.2.11.3 Italy: Gene Editing Market- Revenue and Forecasts to 2030, By Products and Services (USD Million)
      • 11.2.11.4 Italy: Gene Editing Market- Revenue and Forecasts to 2030, By Application (USD Million)
      • 11.2.11.5 Italy: Gene Editing Market- Revenue and Forecasts to 2030, By End User (USD Million)
    • 11.2.12 Spain: Gene Editing Market - Revenue and Forecast to 2030 (USD Million)
      • 11.2.12.1 Spain: Gene Editing Market - Revenue and Forecast to 2030 (USD Million)
      • 11.2.12.2 Spain: Gene Editing Market- Revenue and Forecasts to 2030, By Technology (USD Million)
      • 11.2.12.3 Spain: Gene Editing Market- Revenue and Forecasts to 2030, By Products and Services (USD Million)
      • 11.2.12.4 Spain: Gene Editing Market- Revenue and Forecasts to 2030, By Application (USD Million)
      • 11.2.12.5 Spain: Gene Editing Market- Revenue and Forecasts to 2030, By End User (USD Million)
    • 11.2.13 Rest of Europe: Gene Editing Market - Revenue and Forecast to 2030 (USD Million)
      • 11.2.13.1 Rest of Europe: Gene Editing Market - Revenue and Forecast to 2030 (USD Million)
      • 11.2.13.2 Rest of Europe: Gene Editing Market- Revenue and Forecasts to 2030, By Technology (USD Million)
      • 11.2.13.3 Rest of Europe: Gene Editing Market- Revenue and Forecasts to 2030, By Products and Services (USD Million)
      • 11.2.13.4 Rest of Europe: Gene Editing Market- Revenue and Forecasts to 2030, By Application (USD Million)
      • 11.2.13.5 Rest of Europe: Gene Editing Market- Revenue and Forecasts to 2030, By End User (USD Million)

12. Industry Landscape

  • 12.1 Overview
  • 12.2 Growth Strategies in US and Europe Gene Editing Market
  • 12.3 Organic Growth Strategies
    • 12.3.1 Overview
  • 12.4 Inorganic Growth Strategies
    • 12.4.1 Overview

13. Company Profiles

  • 13.1 Thermo Fisher Scientific Inc
    • 13.1.1 Key Facts
    • 13.1.2 Business Description
    • 13.1.3 Products and Services
    • 13.1.4 Financial Overview
    • 13.1.5 SWOT Analysis
    • 13.1.6 Key Developments
  • 13.2 Merck KGaA
    • 13.2.1 Key Facts
    • 13.2.2 Business Description
    • 13.2.3 Products and Services
    • 13.2.4 Financial Overview
    • 13.2.5 SWOT Analysis
    • 13.2.6 Key Developments
  • 13.3 Lonza Group AG
    • 13.3.1 Key Facts
    • 13.3.2 Business Description
    • 13.3.3 Products and Services
    • 13.3.4 Financial Overview
    • 13.3.5 SWOT Analysis
    • 13.3.6 Key Developments
  • 13.4 Horizon Discovery Group plc.
    • 13.4.1 Key Facts
    • 13.4.2 Business Description
    • 13.4.3 Products and Services
    • 13.4.4 Financial Overview
    • 13.4.5 SWOT Analysis
    • 13.4.6 Key Developments
  • 13.5 Integrated DNA Technologies, Inc.
    • 13.5.1 Key Facts
    • 13.5.2 Business Description
    • 13.5.3 Products and Services
    • 13.5.4 Financial Overview
    • 13.5.5 SWOT Analysis
    • 13.5.6 Key Developments
  • 13.6 GenScript Biotech Corporation
    • 13.6.1 Key Facts
    • 13.6.2 Business Description
    • 13.6.3 Products and Services
    • 13.6.4 Financial Overview
    • 13.6.5 SWOT Analysis
    • 13.6.6 Key Developments
  • 13.7 New England Biolabs
    • 13.7.1 Key Facts
    • 13.7.2 Business Description
    • 13.7.3 Products and Services
    • 13.7.4 Financial Overview
    • 13.7.5 SWOT Analysis
    • 13.7.6 Key Developments
  • 13.8 Eurofins Scientific SE
    • 13.8.1 Key Facts
    • 13.8.2 Business Description
    • 13.8.3 Products and Services
    • 13.8.4 Financial Overview
    • 13.8.5 SWOT Analysis
    • 13.8.6 Key Developments
  • 13.9 CRISPR Therapeutics
    • 13.9.1 Key Facts
    • 13.9.2 Business Description
    • 13.9.3 Products and Services
    • 13.9.4 Financial Overview
    • 13.9.5 SWOT Analysis
    • 13.9.6 Key Developments
  • 13.10 Editas Medicine Inc
    • 13.10.1 Key Facts
    • 13.10.2 Business Description
    • 13.10.3 Products and Services
    • 13.10.4 Financial Overview
    • 13.10.5 SWOT Analysis
    • 13.10.6 Key Developments
  • 13.11 ElevateBio LLC
    • 13.11.1 Key Facts
    • 13.11.2 Business Description
    • 13.11.3 Products and Services
    • 13.11.4 Financial Overview
    • 13.11.5 SWOT Analysis
    • 13.11.6 Key Developments

14. Appendix

  • 14.1 Glossary of Terms

List Of Tables

  • Table 1. US: Gene Editing Market, By Technology - Revenue and Forecast to 2030 (USD Million)
  • Table 2. US: Gene Editing Market, By Products and Services - Revenue and Forecast to 2030 (USD Million)
  • Table 3. US: Gene Editing Market, By Application- Revenue and Forecast to 2030 (USD Million)
  • Table 4. US: Gene Editing Market, By End User- Revenue and Forecast to 2030 (USD Million)
  • Table 5. Europe: Gene Editing Market, By Technology - Revenue and Forecast to 2030 (USD Million)
  • Table 6. Europe: Gene Editing Market, By Products and Services - Revenue and Forecast to 2030 (USD Million)
  • Table 7. Europe: Gene Editing Market, By Application- Revenue and Forecast to 2030 (USD Million)
  • Table 8. Europe: Gene Editing Market, By End User- Revenue and Forecast to 2030 (USD Million)
  • Table 9. Germany: Gene Editing Market, By Technology - Revenue and Forecast to 2030 (USD Million)
  • Table 10. Germany: Gene Editing Market, By Products and Services - Revenue and Forecast to 2030 (USD Million)
  • Table 11. Germany: Gene Editing Market, By Application- Revenue and Forecast to 2030 (USD Million)
  • Table 12. Germany: Gene Editing Market, By End User- Revenue and Forecast to 2030 (USD Million)
  • Table 13. UK: Gene Editing Market, By Technology - Revenue and Forecast to 2030 (USD Million)
  • Table 14. UK: Gene Editing Market, By Products and Services - Revenue and Forecast to 2030 (USD Million)
  • Table 15. UK: Gene Editing Market, By Application- Revenue and Forecast to 2030 (USD Million)
  • Table 16. UK: Gene Editing Market, By End User- Revenue and Forecast to 2030 (USD Million)
  • Table 17. France: Gene Editing Market, By Technology - Revenue and Forecast to 2030 (USD Million)
  • Table 18. France: Gene Editing Market, By Products and Services - Revenue and Forecast to 2030 (USD Million)
  • Table 19. France: Gene Editing Market, By Application- Revenue and Forecast to 2030 (USD Million)
  • Table 20. France: Gene Editing Market, By End User- Revenue and Forecast to 2030 (USD Million)
  • Table 21. Italy: Gene Editing Market, By Technology - Revenue and Forecast to 2030 (USD Million)
  • Table 22. Italy: Gene Editing Market, By Products and Services - Revenue and Forecast to 2030 (USD Million)
  • Table 23. Italy: Gene Editing Market, By Application- Revenue and Forecast to 2030 (USD Million)
  • Table 24. Italy: Gene Editing Market, By End User- Revenue and Forecast to 2030 (USD Million)
  • Table 25. Spain: Gene Editing Market, By Technology - Revenue and Forecast to 2030 (USD Million)
  • Table 26. Spain: Gene Editing Market, By Products and Services - Revenue and Forecast to 2030 (USD Million)
  • Table 27. Spain: Gene Editing Market, By Application- Revenue and Forecast to 2030 (USD Million)
  • Table 28. Spain: Gene Editing Market, By End User- Revenue and Forecast to 2030 (USD Million)
  • Table 29. Rest of Europe: Gene Editing Market, By Technology - Revenue and Forecast to 2030 (USD Million)
  • Table 30. Rest of Europe: Gene Editing Market, By Products and Services - Revenue and Forecast to 2030 (USD Million)
  • Table 31. Rest of Europe: Gene Editing Market, By Application- Revenue and Forecast to 2030 (USD Million)
  • Table 32. Rest of Europe: Gene Editing Market, By End User- Revenue and Forecast to 2030 (USD Million)
  • Table 33. Recent Organic Growth Strategies in US and Europe Gene Editing Market
  • Table 34. Recent Inorganic Growth Strategies in the US and Europe Gene Editing Market
  • Table 35. Glossary of Terms, Gene Editing Market

List Of Figures

  • Figure 1. Gene Editing Market Segmentation
  • Figure 2. Gene Editing Market Segmentation, by Region
  • Figure 3. US and Europe Gene Editing Market Overview
  • Figure 4. CRISPR Segment Held Largest Share of Gene Editing Market
  • Figure 5. UK to Show Significant Growth During Forecast Period
  • Figure 6. US and Europe Gene Editing Market - Leading Country Markets (US$ Million)
  • Figure 7. US and Europe Gene Editing Market, Industry Landscape
  • Figure 8. US PEST Analysis
  • Figure 9. Europe PEST Analysis
  • Figure 10. Gene Editing Market - Key Industry Dynamics
  • Figure 11. Gene Editing Market Impact Analysis of Drivers and Restraints
  • Figure 12. US and Europe Gene Editing Market - Revenue Forecast and Analysis - 2020-2030
  • Figure 13. Market Positioning of Key Players in US and Europe Gene Editing Market
  • Figure 14. US and Europe Gene Editing Market, By Technology 2022 & 2030 (%)
  • Figure 15. US and Europe Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 16. US and Europe TALEN Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 17. US and Europe Antisense Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 18. US and Europe Zinc Finger Nucleases (ZFNs) Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 19. US and Europe Others Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 20. US and Europe Gene Editing Market, By Products and Services 2022 & 2030 (%)
  • Figure 21. US and Europe Reagents and Consumables Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 22. US and Europe Instruments Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 23. US and Europe Others Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 24. US and Europe Gene Editing Market, By Application 2022 & 2030 (%)
  • Figure 25. US and Europe Cell Line Engineering Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 26. US and Europe Genetic Engineering Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 27. US and Europe Diagnostic Application Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 28. US and Europe Drug Discovery Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 29. US and Europe Others Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 30. US and Europe Gene Editing Market, By End User 2022 & 2030 (%)
  • Figure 31. US and Europe Pharmaceutical & Biotechnology Companies Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 32. US and Europe Academic and Research Institutes Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 33. US and Europe Contract Research Organization (CROs) Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 34. US and Europe Others Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 35. US Gene Editing Market- Revenue Forecast and Analysis - 2020- 2030
  • Figure 36. Europe Gene Editing Market- Revenue Forecast and Analysis - 2020- 2030
  • Figure 37. Europe: Gene Editing Market -Revenue and Forecasts to 2030, By Country (%)
  • Figure 38. Germany: Gene Editing Market - Revenue and Forecast to 2030 (USD Million)
  • Figure 39. UK: Gene Editing Market - Revenue and Forecast to 2030 (USD Million)
  • Figure 40. France: Gene Editing Market - Revenue and Forecast to 2030 (USD Million)
  • Figure 41. Italy: Gene Editing Market - Revenue and Forecast to 2030 (USD Million)
  • Figure 42. Spain: Gene Editing Market - Revenue and Forecast to 2030 (USD Million)
  • Figure 43. Rest of Europe: Gene Editing Market - Revenue and Forecast to 2030 (USD Million)
  • Figure 44. Growth Strategies in US and Europe Gene Editing Market